Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Reinventing type 2 diabetes: pathogenesis, treatment, and prevention.

Unger RH.

JAMA. 2008 Mar 12;299(10):1185-7. doi: 10.1001/jama.299.10.1185. No abstract available.

PMID:
18334695
2.

Insulin therapy and lipid overload in type 2 diabetes.

Dandona P, Chaudhuri A, Ghanim H.

JAMA. 2008 Aug 20;300(7):788-9; author reply 790. doi: 10.1001/jama.300.7.788-b. No abstract available.

PMID:
18714056
3.

Insulin therapy and lipid overload in type 2 diabetes.

Marfella R, Barbieri M, Paolisso G.

JAMA. 2008 Aug 20;300(7):789; author reply 790. doi: 10.1001/jama.300.7.789. No abstract available.

PMID:
18714057
4.

[Glucotoxicity and lipotoxicity: factors in the pathogenesis and evolution of type 2 diabetes].

Durruty P, García de los Ríos M.

Rev Med Chil. 2001 Jun;129(6):671-9. Review. Spanish.

PMID:
11510210
5.

[Prevention of diabetes mellitus--yes].

Schwarz P.

Dtsch Med Wochenschr. 2014 Mar;139(10):490. doi: 10.1055/s-0033-1360072. Epub 2014 Feb 25. German. No abstract available.

PMID:
24570196
6.

Insulin resistance: cellular and clinical concepts.

Cefalu WT.

Exp Biol Med (Maywood). 2001 Jan;226(1):13-26. Review.

PMID:
11368233
7.

[From the natural history of non-insulin-dependent diabetes and its etiopathogenesis].

Brogard JM, Robillart I.

Rev Med Interne. 1994;15 Suppl 3:266S-269S. French. No abstract available.

PMID:
7863130
8.

Role of vitamin D in the development of insulin resistance and type 2 diabetes.

Pilz S, Kienreich K, Rutters F, de Jongh R, van Ballegooijen AJ, Grübler M, Tomaschitz A, Dekker JM.

Curr Diab Rep. 2013 Apr;13(2):261-70. doi: 10.1007/s11892-012-0358-4. Review.

PMID:
23264189
9.

Pathogenesis of type 2 diabetes mellitus.

Dostou J, Gerich J.

Exp Clin Endocrinol Diabetes. 2001;109 Suppl 2:S149-56.

PMID:
11460566
10.

Role of insulin resistance and diet in acne.

Kumari R, Thappa DM.

Indian J Dermatol Venereol Leprol. 2013 May-Jun;79(3):291-9. doi: 10.4103/0378-6323.110753. Review.

11.
12.

Cellular and molecular mechanisms of non-insulin dependent diabetes mellitus.

Kruszynska YT, Olefsky JM.

J Investig Med. 1996 Oct;44(8):413-28. Review. No abstract available.

PMID:
8952222
13.

Dietary fat and the development of type 2 diabetes.

Marshall JA, Bessesen DH.

Diabetes Care. 2002 Mar;25(3):620-2. Review. No abstract available.

PMID:
11874958
15.

Current concepts and controversies in the pathogenesis, prevention, and treatment of the macrovascular complications of diabetes.

Mazzone T.

J Lab Clin Med. 2000 Jun;135(6):437-43. Review. No abstract available.

PMID:
10850642
16.

Mesenchymal stem cells for the treatment of diabetes.

Pileggi A.

Diabetes. 2012 Jun;61(6):1355-6. doi: 10.2337/db12-0355. No abstract available.

17.

Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM?

Taylor SI, Accili D, Imai Y.

Diabetes. 1994 Jun;43(6):735-40. Review. No abstract available.

PMID:
8194657
18.
19.

Insulin resistance and hyperglycemic associated risk factors: session summary.

Després JP.

Diabetes Care. 1999 Apr;22 Suppl 3:C38-40. Review. No abstract available.

PMID:
10375290
20.

Redefining treatment choice in type 2 diabetes: highlights of the Experts' Forum Meeting, Monte Carlo, 4-7 May 2000.

Standl E.

J Diabetes Complications. 2001 May-Jun;15(3):162-6. No abstract available.

PMID:
11358686
Items per page

Supplemental Content

Write to the Help Desk